TREA

86790734 - GLYCODX

Follow

Information

  • Trademark
  • 86790734
  • Serial Number
    86790734
  • Registration Number
    5583190
  • Filing Date
    October 16, 2015
    9 years ago
  • Registration Date
    October 16, 2018
    6 years ago
  • Transaction Date
    March 27, 2024
    11 months ago
  • Status Date
    October 16, 2018
    6 years ago
  • Published for Opposition Date
    July 31, 2018
    6 years ago
  • Location Date
    October 16, 2018
    6 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    HACK, ANDREA R
  • Attorney Docket Number
    10054032
    Attorney Name
    Ran He
    Law Office Assigned Location Code
    L80
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
GLYCODX
Case File Statements
  • GS0051: amino acids for medical purposes; biological preparations for the treatment of immune system related diseases, cancer and infectious diseases for medical purposes; blood for medical purposes; blood plasma; capsules sold empty for pharmaceuticals; chemical reagents for medical purposes; chemical preparations for medical purposes, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer and infectious diseases; chemical preparations for pharmaceutical purposes, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer and infectious diseases; chemico-pharmaceutical preparations for the treatment of immune system related diseases, cancer and infectious diseases for medical purposes; detergents for medical purposes; diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; drugs for medical purpose, namely, pharmaceutical preparations for the treatment of immune system related diseases, cancer and infectious diseases; pharmaceutical preparations for treatment of immune system related diseases, cancer and infectious diseases; reagent paper for medical purposes; medicated serums for treatment of immune system related diseases, cancer and infectious diseases; sugar for medical purposes; vaccines; Anti-cancer preparations; Biological preparations for the treatment of cancer; Diagnostic agents, preparations and substances for medical purposes; Diagnostic kits consisting primarily of monoclonal antibodies, buffers and reagents for use in disease testing; Diagnostic preparations for medical or veterinary purposes; Diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; Diagnostic radiopharmaceutical preparations; Diagnostic reagents for medical use; Diagnostic reagents and contrast media for medical use; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; In-vivo diagnostic agent used for detection and monitoring of angiogenesis and antiangiogenic therapy; Medical diagnostic reagents; Medical diagnostic reagents and assays for testing body fluids; Medical diagnostic reagents for the analysis of body fluids; Medicinal preparations for the treatment of infectious diseases and for using in oncology; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Reagents for medical use; Vaccine adjuvants; Vaccine preparations; Vaccine stabilizers
Case File Event Statements
  • 3/27/2024 - 11 months ago
    51 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 3/27/2024 - 11 months ago
    50 - TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED Type: EWOR
  • 3/27/2024 - 11 months ago
    49 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 3/27/2024 - 11 months ago
    48 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 3/27/2024 - 11 months ago
    47 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 3/27/2024 - 11 months ago
    46 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 10/16/2023 - a year ago
    45 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1
  • 10/16/2018 - 6 years ago
    44 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 7/31/2018 - 6 years ago
    43 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 7/31/2018 - 6 years ago
    42 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 7/11/2018 - 6 years ago
    41 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 6/22/2018 - 6 years ago
    40 - 1(B) BASIS DELETED; NEW BASIS REQUESTED Type: ADBS
  • 6/22/2018 - 6 years ago
    39 - NOTICE OF ALLOWANCE CANCELLED Type: IUCN
  • 6/21/2018 - 6 years ago
    38 - ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED Type: ATRQ
  • 6/21/2018 - 6 years ago
    37 - PETITION TO DIRECTOR - CHANGE BASIS - GRANTED Type: PCBG
  • 6/21/2018 - 6 years ago
    36 - ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED Type: ATRQ
  • 6/21/2018 - 6 years ago
    35 - PETITION TO DIRECTOR - CHANGE BASIS - GRANTED Type: PCBG
  • 6/12/2018 - 6 years ago
    34 - TEAS RESPONSE TO PETITION INQUIRY LETTER Type: ERTI
  • 6/4/2018 - 6 years ago
    33 - PETITION INQUIRY LETTER ISSUED Type: PILM
  • 6/1/2018 - 6 years ago
    32 - ASSIGNED TO PETITION STAFF Type: APET
  • 5/1/2018 - 6 years ago
    31 - PAPER RECEIVED Type: MAIL
  • 4/27/2018 - 6 years ago
    30 - TEAS PETITION TO AMEND BASIS RECEIVED Type: TPAD
  • 3/28/2018 - 6 years ago
    29 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 3/26/2018 - 6 years ago
    28 - SOU EXTENSION 3 GRANTED Type: EX3G
  • 3/26/2018 - 6 years ago
    27 - SOU EXTENSION 3 FILED Type: EXT3
  • 3/26/2018 - 6 years ago
    26 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 2/20/2018 - 7 years ago
    25 - ASSIGNED TO EXAMINER Type: DOCK
  • 10/6/2017 - 7 years ago
    24 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 10/4/2017 - 7 years ago
    23 - SOU EXTENSION 2 GRANTED Type: EX2G
  • 10/4/2017 - 7 years ago
    22 - SOU EXTENSION 2 FILED Type: EXT2
  • 10/4/2017 - 7 years ago
    21 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 3/10/2017 - 8 years ago
    20 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 3/8/2017 - 8 years ago
    19 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 3/8/2017 - 8 years ago
    18 - SOU EXTENSION 1 FILED Type: EXT1
  • 3/8/2017 - 8 years ago
    17 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 10/25/2016 - 8 years ago
    16 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 8/30/2016 - 8 years ago
    15 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 8/30/2016 - 8 years ago
    14 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 8/10/2016 - 8 years ago
    13 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 7/26/2016 - 8 years ago
    12 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 7/21/2016 - 8 years ago
    11 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 7/19/2016 - 8 years ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 7/19/2016 - 8 years ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 7/14/2016 - 8 years ago
    8 - ASSIGNED TO LIE Type: ALIE
  • 7/8/2016 - 8 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 2/8/2016 - 9 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 2/8/2016 - 9 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 2/8/2016 - 9 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 2/8/2016 - 9 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 10/21/2015 - 9 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 10/20/2015 - 9 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP